Skip to content

SUPERA S-50-030-120-P6Recalls & reported problems

Abbott Vascular Inc. · Supera Peripheral Stent System 5 mm x 30 mm x 120 cm 6 F · Class 3 · Implant

All models of SUPERA (55)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648211874), received between Mar 17, 2020 and Mar 17, 2020 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Stenosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 17, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE 5.0X30 MM SUPERA STENT WAS IMPLANTED IN THE SUPERFICIAL FEMORAL ARTERY TO TREAT THE PATIENT WITH INTERMITTENT CLAUDICATION. 300 DAYS AFTER THE IMPLANT PROCEDURE, THE PATIENT HAD IN-STENT RESTENOSIS. THIS WAS A PATIENT REFERENCED AS CASE SIX IN THE ARTICLE TITLED, PATHOLOGY AND MULTIMODALITY IMAGING OF ACUTE AND CHRONIC FEMORAL STENTING IN HUMANS.

    Patient problems: Stenosis

    MAUDE report 9842533 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page